Home » Articles

Articles

AB21 spreads presence in Asia with AceBiome

A newly published clinical trial in Gut Microbes – a top journal reporting the latest science in microbiota – has confirmed that Kaneka Group / AB-Biotics’ AB21 probiotic formulation exhibits significant positive effects in COVID-19 outpatients.

AB21 demonstrates benefit in COVID-19 outpatients

A newly published clinical trial in Gut Microbes – a top journal reporting the latest science in microbiota – has confirmed that Kaneka Group / AB-Biotics’ AB21 probiotic formulation exhibits significant positive effects in COVID-19 outpatients.